Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study

CONCLUSIONS: This study, as one of the largest of MPN-U studies incorporating both clinicopathologic and molecular data, moves toward identification of biomarkers that better predict prognosis in this heterogeneous category.PMID:38597584 | DOI:10.1093/ajcp/aqae033

Source: American Journal of Clinical Pathology - April 10, 2024 Category: Pathology Authors: Genevieve M Crane Julia T Geyer Beenu Thakral Sa A Wang Geoffrey D Wool Ke David Li Adam R Davis Leonardo Boiocchi David Bosler Carlos E Bueso-Ramos Daniel A Arber Tracy I George Adam Bagg Robert P Hasserjian Attilio Orazi Eric D Hsi Heesun J Rogers Source Type: research